Literature DB >> 1904396

Nonhomologous recombination in the human genome: deletions in the human factor VIII gene.

P Woods-Samuels1, H H Kazazian, S E Antonarakis.   

Abstract

Four deletions in the human factor VIII gene have been characterized at the sequence level in patients with hemophilia A. Deletion JH 1 extends 57 kb from IVS 10 to IVS 18. Intron 13 and exon 14 are partially deleted in patients JH 7 and JH 37, with a loss of 3.2 and 2.4 kb of DNA, respectively. The 3' deletion breakpoint of the JH 21 event resides in intron 3 and extends 5' into intron 1, resulting in the loss of exons 2 and 3. Seven of the eight breakpoints sequenced (5' and 3' for each of the four deletions) occur in nonrepetitive sequence, while the 3' breakpoint of the JH 1 resides in an Alu repetitive element. All of the deletions are the result of nonhomologous recombination. The 5' and 3' breakpoints of JH 1, JH 7, and JH 37 share 2- to 3-bp homologies at the deletion junctions. In contrast, two nucleotides have been inserted at the JH 21 deletion junction. Short sequence homologies may facilitate end-joining reactions in nonhomologous recombination events.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904396     DOI: 10.1016/0888-7543(91)90489-2

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  A mechanism for deletion formation in DNA by human cell extracts: the involvement of short sequence repeats.

Authors:  J Thacker; J Chalk; A Ganesh; P North
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  An approximately 140-kb deletion associated with feline spinal muscular atrophy implies an essential LIX1 function for motor neuron survival.

Authors:  John C Fyfe; Marilyn Menotti-Raymond; Victor A David; Lars Brichta; Alejandro A Schäffer; Richa Agarwala; William J Murphy; William J Wedemeyer; Brittany L Gregory; Bethany G Buzzell; Meghan C Drummond; Brunhilde Wirth; Stephen J O'Brien
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

4.  Formation of large deletions by illegitimate recombination in the HPRT gene of primary human fibroblasts.

Authors:  T Morris; J Thacker
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

5.  Identification and characterization of new human medium reiteration frequency repeats.

Authors:  J Jurka; D J Kaplan; C H Duncan; J Walichiewicz; A Milosavljevic; G Murali; J F Solus
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

6.  Large DNA inversions, deletions, and TaqI site mutations in severe haemophilia A.

Authors:  M S Figueiredo; M H Tavella; B P Simões
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

7.  The rates and patterns of deletions in the human factor IX gene.

Authors:  R P Ketterling; E L Vielhaber; T J Lind; E C Thorland; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

8.  Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene.

Authors:  E G Tuddenham; D N Cooper; J Gitschier; M Higuchi; L W Hoyer; A Yoshioka; I R Peake; R Schwaab; K Olek; H H Kazazian
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

9.  High-frequency illegitimate integration of transfected DNA at preintegrated target sites in a mammalian genome.

Authors:  R V Merrihew; K Marburger; S L Pennington; D B Roth; J H Wilson
Journal:  Mol Cell Biol       Date:  1996-01       Impact factor: 4.272

10.  Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition.

Authors:  E G Tuddenham; R Schwaab; J Seehafer; D S Millar; J Gitschier; M Higuchi; S Bidichandani; J M Connor; L W Hoyer; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.